Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Kimberly A Johnson

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Alanis-Hirsch K, Croff R, Ford JH, Johnson K, Chalk M, Schmidt L, McCarty D. Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use. J Subst Abuse Treat. 2016 Mar; 62:68-73. PMID: 26654934; PMCID: PMC4724460 [Available on 03/01/17].
    2. Vaidya S, Johnson K, Rogers M, Nash D, Schillinger JA. Predictors of index patient acceptance of expedited partner therapy for Chlamydia trachomatis infection and reasons for refusal, sexually transmitted disease clinics, New York City, 2011 to 2012. Sex Transm Dis. 2014 Nov; 41(11):690-4. PMID: 25299418.
      View in: PubMed
    3. Shegog R, Peskin MF, Markham C, Thiel M, Karny E, Addy RC, Johnson KA, Tortolero S. It's Your Game-Tech: Toward Sexual Health in the Digital Age. Creat Educ. 2014 Aug; 5(15):1428-1447. PMID: 25705561.
      View in: PubMed
    4. Shegog R, Markham CM, Peskin MF, Johnson K, Cuccaro P, Tortolero SR. It's Your Game…Keep It Real: can innovative public health prevention research thrive within a comparative effectiveness research framework? J Prim Prev. 2013 Apr; 34(1-2):89-108. PMID: 23344633; PMCID: PMC3653998.
    5. Johnson KA, Ford JH, McCluskey M. Promoting new practices to increase access to and retention in addiction treatment: an analysis of five communication channels. Addict Behav. 2012 Nov; 37(11):1193-7. PMID: 22771023.
      View in: PubMed
    6. Johnson K, Isham A, Shah DV, Gustafson DH. Potential roles for new communication technologies in treatment of addiction. Curr Psychiatry Rep. 2011 Oct; 13(5):390-7. PMID: 21739171; PMCID: PMC3179375.
    7. Alley WM, Hamdemir IK, Wang Q, Frenkel AI, Li L, Yang JC, Menard LD, Nuzzo RG, Özkar S, Yih KH, Johnson KA, Finke RG. Industrial Ziegler-type hydrogenation catalysts made from Co(neodecanoate)2 or Ni(2-ethylhexanoate)2 and AlEt3: evidence for nanoclusters and sub-nanocluster or larger Ziegler-nanocluster based catalysis. Langmuir. 2011 May 17; 27(10):6279-94. PMID: 21480617.
      View in: PubMed
    8. Gustafson DH, Boyle MG, Shaw BR, Isham A, McTavish F, Richards S, Schubert C, Levy M, Johnson K. An e-health solution for people with alcohol problems. Alcohol Res Health. 2011; 33(4):327-37. PMID: 23293549; PMCID: PMC3536059.
    9. Alley WM, Hamdemir IK, Wang Q, Frenkel AI, Li L, Yang JC, Menard LD, Nuzzo RG, Ozkar S, Johnson KA, Finke RG. Iridium Ziegler-type hydrogenation catalysts made from [(1,5-COD)Ir(mu-O2C8H15)](2) and AlEt3: spectroscopic and kinetic evidence for the Ir(n) species present and for nanoparticles as the fastest catalyst. Inorg Chem. 2010 Sep 06; 49(17):8131-47. PMID: 20681520.
      View in: PubMed
    Johnson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)